NovaBay Pharmaceuticals, Inc. — Director's Dealing 2021

Dec 6, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NovaBay Pharmaceuticals, Inc. (NBY)
CIK: 0001389545
Period of Report: 2021-12-03

Reporting Person: Jones Andrew D. (CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-12-03	Common Stock	P	8690	$0.44	Acquired	90696	Direct
2021-12-06	Common Stock	P	36765	$0.44	Acquired	127461	Direct